Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TES study for uncomplicated falciparum malaria in Ugandan children
PACTR202301796134887Phase 4Recruiting
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of artemether + lumefantrine, dihydroartemisinin + piperaquine, artesunate + pyronaridine and artesunate + amodiaquine in malaria and Malaria (4 arms). Primary endpoints: Therapeutic efficacy response categories and PCR-corrected recrudescence versus reinfection. Started Nov 2022; status: recruiting.
02
Drugs
artemether + lumefantrinedihydroartemisinin + piperaquineartesunate + pyronaridineartesunate + amodiaquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on PACTR202301796134887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202301796134887.